Patents by Inventor Sung-II Yun

Sung-II Yun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240143927
    Abstract: Provided are a method for generating a summary and a system therefor. The method according to some embodiments may include calculating a likelihood loss for a summary model using a first text sample and a first summary sentence corresponding to the first text sample, calculating an unlikelihood loss for the summary model using a second text sample and the first summary sentence, the second text sample being a negative sample generated from the first text sample, and updating the summary model based on the likelihood loss and the unlikelihood loss.
    Type: Application
    Filed: October 26, 2023
    Publication date: May 2, 2024
    Applicants: SAMSUNG SDS CO., LTD., SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
    Inventors: Sung Roh YOON, Bong Kyu HWANG, Ju Dong KIM, Jae Woong YUN, Hyun Jae LEE, Hyun Jin CHOI, Jong Yoon SONG, Noh II PARK, Seong Ho JOE, Young June GWON
  • Publication number: 20230203494
    Abstract: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
    Type: Application
    Filed: December 16, 2022
    Publication date: June 29, 2023
    Inventors: Tae-Rim KIM, Pyoung Oh YOON, Youngho KO, Seon Joo BAE, Han-Oh PARK, Seung Seob SON, Jun-Hong PARK, Sung-II YUN
  • Publication number: 20220118093
    Abstract: Disclosed are a double stranded oligonucleotide construct, configured such that a hydrophilic material and a hydrophobic material are conjugated through a simple covalent bond or a linker-mediated covalent bond to both ends of a double stranded oligonucleotide in order to efficiently deliver an androgen-receptor-specific oligonucleotide into a cell, a nanoparticle capable of being produced by self-assembling double stranded oligonucleotide constructs in an aqueous solution through hydrophobic interactions, and a composition for preventing hair loss or promoting hair growth containing the double stranded oligonucleotide construct.
    Type: Application
    Filed: November 18, 2019
    Publication date: April 21, 2022
    Inventors: Han-Oh PARK, Sung II YUN, Sang-Jin BYUN, Myeong-Mi LEE, Seung Ya YANG
  • Publication number: 20220088051
    Abstract: The present invention pertains to: a double-stranded oligonucleotide construct having a structure in which a hydrophilic substance and a hydrophobic substance are conjugated by a simple covalent bond or a linker-mediated covalent bond at both ends of a DKK1-specific double-stranded oligonucleotide to efficiently deliver the double-stranded oligonucleotide into cells; a nanoparticle capable of being produced through self-assembly of the double-stranded oligonucleotide construct through a hydrophobic interaction in an aqueous solution; and a hair-loss-preventing and hair-growth-promoting composition containing the double-stranded oligonucleotide construct or the nanoparticle.
    Type: Application
    Filed: January 15, 2020
    Publication date: March 24, 2022
    Inventors: Han-Oh PARK, Sung II YUN, Sang-Jin BYUN, Pyoung Oh YOON, Sang-Kyu LEE, Tae-Rim KIM, Young-Ho KO, Seung-Seob SON, Eun-Ah GOH, Hyung-Jin KIM
  • Publication number: 20210189398
    Abstract: The present invention relates to a double-stranded oligonucleotide which can highly specifically and efficiently inhibit an amphiregulin expression and, preferably, a double-stranded oligonucleotide comprising a sequence in the form of RNA/RNA, DNA/DNA or DNA/RNA hybrid, a double-stranded oligonucleotide structure comprising the double-stranded oligonucleotide, nanoparticles comprising the double-stranded oligonucleotide structure, and a fibrosis or respiratory disease preventive or therapeutic use thereof.
    Type: Application
    Filed: May 22, 2019
    Publication date: June 24, 2021
    Inventors: Tae-Rim KIM, Pyoung Oh YOON, Youngho KO, Seon Joo BAE, Han-Oh PARK, Seung Seob SON, Jun-Hong PARK, Sung-II YUN
  • Publication number: 20160168573
    Abstract: There is provided a liver cancer related specific siRNA and high efficiency double-stranded oligo RNA molecules containing the same. The double-stranded oligo RNA molecules have a structure in which hydrophilic and hydrophobic compounds are conjugated to both ends of the double-stranded oligo RNA molecules by a simple covalent bond or a linker-mediated covalent bond in order to be efficiently delivered into cells and may be converted into nanoparticles in an aqueous solution by hydrophobic interactions of the double-stranded oligo RNA molecules. The siRNA contained in the double-stranded oligo RNA molecules may be liver cancer related genes, particularly Gankyrin or BMI-1 specific siRNA. In addition, the present invention relates to a method of preparing the double-stranded oligo RNA molecules, and a pharmaceutical composition for preventing or treating cancer, particularly, liver cancer, containing the double-stranded oligo RNA molecules.
    Type: Application
    Filed: July 9, 2014
    Publication date: June 16, 2016
    Inventors: Jeiwook Chae, Han Oh Park, Pyoung Oh Yoon, Boram Han, Han-na Kim, Sung-II Yun, Jun Hong Park, Youngho Ko, Gi-Eun Choi, Junsoo Jung, Jae Eun Kim